Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics
Movement Disorders · 2025-10 · 40 (10) · 2116-2128
DOI: 10.1002/mds.30261 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Movement Disorders, online erschienen am 12.06.2025. Verfasst von Sarah Wrigley und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom. Hauptthemen laut MEDLINE: Supranuclear Palsy, Progressive, Multiple System Atrophy, Lewy Body Disease, Corticobasal Degeneration. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
Background
Several neurodegenerative diseases can mimic the clinical presentation of progressive supranuclear palsy (PSP), limiting accurate diagnosis during life. This has important implications for clinical practice, biomarker studies, and therapeutic trial design.
Objectives
To investigate whether the proportion of clinically diagnosed PSP patients with non‐PSP pathology (termed ‘mimics’) has changed over the past 20 years since last examined in this cohort, and to identify clinical features that distinguish confirmed PSP from these mimics.
Methods
We reviewed the clinical records of pathologically confirmed PSP patients donated to the Queen Square Brain Bank from 2010 to 2022, and PSP mimics donated from 1989 to 2022. Demographic information, clinical features, and progression milestones were recorded.
Results
We included 236 pathologically confirmed PSP patients and 72 mimics. The main pathologies in PSP mimics were Lewy body disease (30.5%), corticobasal degeneration (23.6%), and multiple system atrophy (18.1%). A final clinical diagnosis of PSP between 2010 and 2022 had a positive predictive value of 86% for underlying PSP pathology and a false negative rate of 17%. Clinical features present in the first 3 years that favoured non‐PSP pathology in this cohort include levodopa responsiveness, orthostatic hypotension, dysarthria, and a subcortical phenotype.
Conclusions
Clinical diagnosis of PSP has improved since last examined in this cohort 20 years ago. Although certain clinical features may point to non‐PSP pathologies, a proportion of patients are difficult to distinguish on clinical grounds alone. This should be reflected in clinical trial design, and further studies will be required to determine the utility of emerging biomarkers in this setting. © 2025 International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, University College London, London, United Kingdom.
- Queen Square Brain Bank for Neurological Disorders, UCL Queen Square Institute of Neurology, London, United Kingdom.
- Reta Lila Weston Institute of Neurological Studies, UCL Queen Square Institute of Neurology, London, United Kingdom.
- Queen Square Movement Disorders Centre, UCL Queen Square Institute of Neurology, London, United Kingdom.
- Department of Neurology, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo (HC-FMUSP), São Paulo, Brazil.
- Division of Neuropathology, National Hospital for Neurology and Neurosurgery, University College London NHS Foundation Trust, London, United Kingdom.
ORCID-Profile: Sarah Wrigley, Patrick W Cullinane, Jacy Bezerra Parmera, María Rivera-Sánchez, Toby Curless, Huw R Morris, Thomas T Warner
Zitieren
APA
Wrigley, S., Cullinane, P. W., Parmera, J. B., Arca, V. M., Sifontes Valladares, W., Rivera-Sánchez, M., Curless, T., Chajed, L. P., Burrows, M., Revesz, T., Morris, H. R., Jaunmuktane, Z., Warner, T. T., & de Pablo-Fernández, E. (2025). Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics. Movement Disorders, 40(10), 2116-2128. https://doi.org/10.1002/mds.30261
Vancouver
Wrigley S, Cullinane PW, Parmera JB, Arca VM, Sifontes Valladares W, Rivera-Sánchez M, et al. Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics. Movement Disorders. 2025;40(10):2116-2128. doi:10.1002/mds.30261
BibTeX
@article{Wrigley2025,
author = {Wrigley, Sarah and Cullinane, Patrick W and Parmera, Jacy Bezerra and Arca, Vitor Maia and Sifontes Valladares, Walter and Rivera-Sánchez, María and Curless, Toby and Chajed, Leckhna Paras and Burrows, Maggie and Revesz, Tamas and Morris, Huw R and Jaunmuktane, Zane and Warner, Thomas T and de Pablo-Fernández, Eduardo},
title = {Clinical Diagnosis of Progressive Supranuclear Palsy (PSP): A Clinicopathological Comparison of Patients with Confirmed PSP and Clinical Mimics},
journal = {Movement Disorders},
year = {2025},
volume = {40},
number = {10},
pages = {2116--2128},
doi = {10.1002/mds.30261}
}
EUVIMED